Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Luz Tarín-Arzaga
Impact of the Affordability of Novel Agents in Patients With Multiple Myeloma: Real-World Data of Current Clinical Practice in Mexico
Cancer
Cancer Research
Oncology
Related publications
Value of Novel Agents and Intensive Therapy for Patients With Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Real World Data of the Impact of First Cycle Daratumumab on Multiple Myeloma and AL Amyloidosis Services
British Journal of Haematology
Hematology
Pcn113 - Evaluating the Economic Impact of Novel Agents for Treating Multiple Myeloma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Mo1 - Combining Internally Valid Trial Evidence With Generalizable Real-World Data: Insights Into Effects, Costs, and Cost-Effectiveness of Novel Treatment Sequences in Patients With Multiple Myeloma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Bortezomib: The Evidence of Its Clinical Impact in Multiple Myeloma
Core Evidence
Medicine
Reviews
References
Pharmacology
Clinical Impact of Serum Soluble SLAMF7 in Multiple Myeloma
Oncotarget
Oncology
Persistent Dyslipidemia in Statin-Treated Patients: Russian Real-World Clinical Practice Data (Russian Part of the DYSIS Study)
Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular Medicine
Cardiology
The USE MODIFIED RISK STRATIFICATION mSMART 3.0 IN REAL CLINIC PRACTICE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
